September 23-24, 2026 | Part of Biotech Week Boston
Hynes Convention CenterBoston, United States Tom HsuScientist at IbioSpeaker
Profile
Dr. Tom Hsu is a Scientist at iBio specializing in drug discovery and translational research for metabolic and cardiometabolic diseases. His work focuses on the discovery and preclinical development of antibody- and peptide-based therapeutics, with expertise in pharmacology, assay development, and mechanism-of-action studies. Dr. Hsu has contributed to multiple therapeutic programs advancing innovative biologics toward clinical development.
Agenda Sessions
A Precision Antibody Approach to Maximise Weight-Loss and Muscle Mass Preservation
, 11:40View Session